Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram website >

January 29, 2007

Pietenpol Named Interim Director of Vanderbilt-Ingram Cancer Center

Jennifer A. Pietenpol, Ph.D., has been selected to lead the Vanderbilt-Ingram Cancer Center as interim director.
January 10, 2007

Vanderbilt-Ingram Cancer Center Director To Return To Home State For Post At MD Anderson

Raymond DuBois Jr., M.D., Ph.D., will leave his position as director of the Vanderbilt-Ingram Cancer Center later this year to return to his native Texas as provost and executive vice president of academic affairs at M.D. Anderson Cancer Center in Houston.
November 28, 2006

MEHARRY/VANDERBILT-INGRAM CANCER PARTNERSHIP AWARDED $14 MILLION GRANT FOR CANCER STUDY

The Meharry/Vanderbilt-Ingram Cancer Partnership has been awarded $14 million by the National Cancer Institute for research that seeks to reduce cancer mortality among African Americans and other minorities.

November 28, 2006

Vanderbilt-Ingram Cancer Center, AstraZeneca Form Master Agreement to Streamline Research Collaborations

The Vanderbilt-Ingram Cancer Center and AstraZeneca have developed a master scientific agreement to streamline and integrate collaborations in basic, translational and clinical cancer research, officials with the company and cancer center announced today.
June 8, 2006

First Adult Cancer Patient in Nashville to Receive Stem Cell Transplant from Umbilical Cord Blood at Vanderbilt-Ingram Cancer Center

When 24-year-old Charles Dougherty checks into Vanderbilt-Ingram Cancer Center tomorrow, he’ll be preparing for a treatment that has never been performed before in an adult patient in Nashville, and will be only the second case in Tennessee history.

By VUMC News and Communications
April 17, 2006

Results of Nationwide Breast Cancer Prevention Trial Show Osteoporosis Drug Raloxifene is as Effective as Tamoxifen in Preventing Invasive Breast Cancer; Vanderbilt-Ingram Cancer Center is Only Regional Participant

Initial Results of the Study of Tamoxifen and Raloxifene or STAR, released today revealed the osteoporosis drug raloxifene has been proved to be as effective as tamoxifen in preventing invasive breast cancer.

By VUMC News and Communications
March 20, 2006

Vanderbilt-Ingram Cancer Center Research Earns Funding from Lance Armstrong Foundation to Study Effects of Exercise on Curbing Memory Problems Associated with Chemotherapy

Researchers at the Vanderbilt-Ingram Cancer Center are studying whether exercise can help curb memory and cognitive problems experienced by many cancer survivors following chemotherapy.
By VUMC News and Communications
March 15, 2006

Vanderbilt-Ingram Cancer Center Researchers Find Ginseng May Improve Breast Cancer Outcomes

Ginseng, one of the most widely used herbs in traditional Chinese medicine, may improve survival and quality of life after a diagnosis of breast cancer, according to a recent study by Vanderbilt-Ingram Cancer Center researchers. The large epidemiological study, led by Xiao-Ou Shu, M.D., Ph.D., was published online recently in the American Journal of Epidemiology.
By VUMC News and Communications
March 8, 2006

Vanderbilt-Ingram Cancer Center Receives Funding to Identify Signals for Breast Cancer in the Blood and Women at High-Risk for the Disease

A team of researchers at Vanderbilt-Ingram Cancer Center has been awarded $1.5 million from the Susan G. Komen Breast Cancer Foundation.
By VUMC News and Communications
February 16, 2006

Vanderbilt-Ingram Cancer Center Researcher Studies Effects of Cancer Treatment among Children of Survivors

Can the high doses of chemotherapy and radiation that young cancer patients receive cause inherited health problems for their children?
By VUMC News and Communications
January 27, 2006

Vanderbilt-Ingram Cancer Center opens mentoring program for patients considering clinical trials

Thanks to Vanderbilt-Ingram Cancer Center's new Clinical Trials Mentor Program, patients considering enrolling in a clinical trial can now ask questions and get first-hand accounts from patient advocates who have already gone through the process.
By VUMC News and Communications
January 25, 2006

Researchers at Vanderbilt-Ingram Cancer Center to conduct Phase II studies for the National Cancer Institute

The Vanderbilt-Ingram Cancer Center has been chosen by the National Cancer Institute to join an elite group of researchers asked to test the most cutting-edge cancer treatments in Phase II clinical trials in both solid tumor and hematologic malignancies.
By VUMC News and Communications
January 10, 2006

Researchers at Vanderbilt-Ingram Cancer Center uncover clue to explain invasive brain tumors

Researchers at the Vanderbilt-Ingram Cancer Center have uncovered a clue to explain the invasive nature of an aggressive kind of brain tumor called glioblastoma multiforme, or gliomas, and their findings are published in this week's online edition of the journal Oncogene.
By VUMC News and Communications
1 … 21 22 23 24 25 26